Telerobotic surgery is moving from isolated demonstrations toward broader clinical and regulatory development, according to a recent MedTech Dive report. The article, “Telerobotic surgery is advancing around the world. Will the US embrace it?,” examined the technology’s progress and the regulatory and infrastructure questions surrounding remote surgery. It highlighted SS Innovations International (NASDAQ: SSII) alongside larger medical-device companies and emerging robotics developers (https://ibn.fm/4ZLvL).
SS Innovations CEO Dr. Sudhir Srivastava told MedTech Dive that robotic surgery is inherently a form of teleoperation and that the central technical question is how much distance can be introduced without compromising responsiveness. The company reported 195 robotic telesurgeries using its SSi Mantra system as of Sept. 28, 2026, including cardiac procedures and long-distance operations. Its installed base reached 244 SSi Mantra systems as of Sept. 28, up 45% from the end of 2025, while cumulative procedures reached 14,503.
The SSi Mantra system has expanded into 12 countries, with recent cardiac-surgery programs launched in Colombia and Sri Lanka and a new program established at HCG Hospital in Ahmedabad. SS Innovations is currently pursuing U.S. FDA clearance and European Union CE marking as it seeks to expand the system into additional international markets. These regulatory efforts are critical because they would open some of the world’s largest and most stringent healthcare markets, potentially accelerating adoption of telerobotic surgery.
The growing interest in telerobotic surgery places SS Innovations and its founder and CEO, cardiac surgeon Dr. Sudhir Srivastava, in an increasingly relevant part of the surgical robotics market. For SS Innovations, the discussion comes as its SSi Mantra system is accumulating experience in telesurgery while the company works toward broader regulatory approvals. The latest news and updates relating to SSII are available in the company’s newsroom at https://ibn.fm/SSII.
MissionIR, a specialized communications platform focused on assisting IR firms with syndicated content, is one of 75+ brands within the Dynamic Brand Portfolio at IBN. The platform provides access to wire solutions via InvestorWire and editorial syndication to 5,000+ outlets, among other services. For more information, visit MissionIR.
